Drug class
Hair Growth Inhibitors, Topical
Topical hair growth inhibitors are dermatologic agents designed to decelerate the rate of follicular hair synthesis rather than act as chemical depilatories. Read more about Hair Growth Inhibitors, Topical
1 drugs in this class 1 manufacturers
Drugs in Hair Growth Inhibitors, Topical
Topical hair growth inhibitors are dermatologic agents designed to decelerate the rate of follicular hair synthesis rather than act as chemical depilatories.
Represented primarily by topical eflornithine, this functional drug grouping works through the irreversible inhibition of epidermal ornithine decarboxylase, an essential enzyme in the biosynthesis of polyamines required for follicular cell proliferation and hair matrix development.
Clinically, these agents are indicated for the management of unwanted facial hair and hirsutism in women, often associated with hyperandrogenism, polycystic ovary syndrome, or idiopathic causes.
They serve as an adjunctive therapeutic modality alongside mechanical or light-based hair reduction methods to sustain smoother skin and prolong inter-treatment intervals.
-
hants.gov.uk
Topical hair growth inhibitors are dermatologic agents designed to decelerate the rate of follicular hair synthesis rather than act as chemical depilatories Clinically, these agents are indicated for the management of unwanted facial hair and hirsutism in women, often associated with hyperandrogenism, polycystic ovary syndrome, or idiopathic causes They serve as an adjunctive therapeutic modality alongside mechanical or light-based hair reduction methods to sustain smoother skin and prolong inte...
-
fda.gov
Topical hair growth inhibitors are dermatologic agents designed to decelerate the rate of follicular hair synthesis rather than act as chemical depilatories Represented primarily by topical eflornithine, this functional drug grouping works through the irreversible inhibition of epidermal ornithine decarboxylase, an essential enzyme in the biosynthesis of polyamines required for follicular cell proliferation and hair matrix development
-
fda.gov
Represented primarily by topical eflornithine, this functional drug grouping works through the irreversible inhibition of epidermal ornithine decarboxylase, an essential enzyme in the biosynthesis of polyamines required for follicular cell proliferation and hair matrix development Clinically, these agents are indicated for the management of unwanted facial hair and hirsutism in women, often associated with hyperandrogenism, polycystic ovary syndrome, or idiopathic causes
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.